|High / Low range:||1.10|
Trading in Novo Nordisk shares by board members, executives and associated persons on 11 February 2020
Bagsværd, Denmark, 14 February 2020 — This
document discloses the data of the transaction(s) made in
Novo Nordisk shares by the company’s board members,
executives and their associated persons in accordance with
Article 19 of Regulation No. 596/2014 on market abuse.
The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.
See attached pdf for details.
|Mette Kruse Danielsen||+45 4442 email@example.com|
|Ken Inchausti (US)||+1 609 240 firstname.lastname@example.org|
|Peter Hugreffe Ankersen||+45 3075 email@example.com|
|Valdemar Borum Svarrer||+45 3079 firstname.lastname@example.org|
|Ann Søndermølle Rendbæk||+45 3075 email@example.com|
|Mark Joseph Root||+45 3079 firstname.lastname@example.org|
|Kristoffer Due Berg US)||+1 609 235 email@example.com|
Company announcement No 10/2020
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.